Prostate cancer is one of the most prevalent cancer types in men over 40. 4Kscore® Test is a novel approach for urologists and patients, for determining the risk of aggressive (Gleason 7 or higher) prostate cancer. The 4Kscore® Test will dramatically increase the accuracy of prostate cancer diagnosis, particularly in its most aggressive forms.
What are the benefits of the 4Kscore® test?
Also, by avoiding a diagnosis of a low-grade, non-life threatening form of prostate cancers (Gleason score = 6), the patient may avoid treatments that he may not need. In addition, a major European study has demonstrated the 4Kscore® test predicts the probability of distant metastases within 15 years.
The test has been developed as a result of over 10 years of research in Europe and The United States and has gained a lot of popularity due to being easier on the patient and by giving the doctors additional information to make the correct decisions.
If You’re interested in the test and would like to start offering it in Your practice in Northern Europe, please contact us at firstname.lastname@example.org
The 4Kscore® Test is for any man concerned about his risk for high-grade, aggressive prostate cancer, and is especially useful when considering a prostate biopsy. The 4Kscore® test provides information that a man and his Urologist can use to make an informed, shared decision about whether or not to perform a prostate biopsy
If You’d like to know Your personal risk of having aggressive prostate cancer, please ask Your urologist about the 4kscore® or see below for the list of 4Kscore® test providers in the region.
Clinics offering the 4Kscore® Test in Estonia
Clinics offering the 4Kscore® Test in Finland
Clinics offering the 4Kscore® Test in Latvia
Radiosurgery Centre Sigulda
Dr.Maris Mežeckis Private Practice
– Mob.+371 261 79 193
4Kscore® Test is applicable to men, who:
– are 40 to 80 years old
– have an elevated PSA level
– don’t have a previous prostate cancer diagnosis
– have not used 5α-reductase inhibitors in the past 6 months
– have not had a prostate biopsy in the past 6 months
– have not had a digital rectal exam (DRE) or other invasive prostate procedures in the past 96 hours